Doctors in Pennsylvania reported this week that combining immunotherapy drugs with radiotherapy could help to more efficiently treat malignant pleural mesothelioma.
The analysis from the University of Pennsylvania looked at studies that combined immunotherapy drugs like Merck‘s (NYSE:MRK) Keytruda with radiation therapy. The team concluded that radiotherapy may boost the cancer-killing effects of immunotherapies.
Get the full story at our sister site, Drug Delivery Business News.
The post Study: Radiation may boost immunotherapy in mesothelioma treatment appeared first on MassDevice.
from MassDevice http://ift.tt/2rDT7KA
Cap comentari:
Publica un comentari a l'entrada